Physician profile
Eric M Cheung
NPI 1881872687
$39,835.50
in general payments reported to CMS, 2019-2025
100 companies · $8,272 in 2025
The $8,272 reported for 2025 was more than what 87% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,659 · 2020: $2,573 · 2021: $3,458 · 2022: $6,037 · 2023: $7,200 · 2024: $8,637 · 2025: $8,272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $21K · Long Term Medical Supply Or Device Loan: $2,115 · Education: $1,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20,944.22 |
| Long Term Medical Supply Or Device Loan | $2,114.51 |
| Education | $1,049.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $4,486.85 | 2019-2025 | |
| Pfizer INC. | $2,329.89 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,777.72 | 2019-2025 | Calquence, Lynparza, Tagrisso |
| Janssen Biotech, INC. | $1,753.26 | 2019-2025 | Imbruvica, Erleada, Darzalex |
| Verastem, INC. | $1,704.84 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $1,454.96 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Incyte Corporation | $1,363.36 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Eisai INC. | $1,335.35 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,307.08 | 2019-2025 | Opdivo, Opdualag, Eliquis |
| Celgene Corporation | $1,246.57 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Astellas Pharma US INC | $1,162.14 | 2019-2025 | Xtandi, Vyloy, Xospata |
| Bayer Healthcare Pharmaceuticals INC. | $1,142.88 | 2019-2025 | |
| Abbvie INC. | $1,111.31 | 2019-2025 | Venclexta, Lupron Depot |
| Regeneron Healthcare Solutions, INC. | $1,007.36 | 2019-2025 | Libtayo, Lynozyfic |
| Gilead Sciences, INC. | $791.09 | 2019-2025 | Trodelvy |
Show all 100 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $784.30 | 2019-2025 | Fruzaqla, Iclusig, Alunbrig |
| Genentech USA, INC. | $726.72 | 2019-2025 | Tecentriq, Polivy, Phesgo |
| Pharmacyclics LLC, An Abbvie Company | $695.66 | 2019-2023 | Imbruvica |
| Lilly USA, LLC | $640.69 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Genzyme Corporation | $630.70 | 2019-2025 | |
| Daiichi Sankyo INC. | $547.46 | 2021-2025 | Enhertu, Datroway, Vanflyta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $512.38 | 2019-2025 | Gilotrif |
| Beigene USA, INC. | $485.36 | 2021-2025 | Brukinsa, Tevimbra |
| Exelixis INC. | $480.69 | 2019-2025 | Cabometyx |
| Karyopharm Therapeutics INC. | $440.87 | 2021-2025 | Xpovio |
| Alexion Pharmaceuticals, INC. | $430.52 | 2019-2025 | Ultomiris |
| Sobi, INC | $419.70 | 2021-2025 | |
| Puma Biotechnology, INC. | $391.65 | 2019-2025 | |
| Aveo Pharmaceuticals, INC. | $380.50 | 2021-2025 | Fotivda |
| Array Biopharma INC | $372.27 | 2020-2025 | Braftovi, Mektovi, Tukysa |
| Seagen INC. | $359.62 | 2019-2025 | Tivdak |
| Janssen Pharmaceuticals, INC | $326.21 | 2019-2024 | Xarelto |
| Rigel Pharmaceuticals, INC. | $314.45 | 2019-2025 | Rezlidhia, Tavalisse, Gavreto |
| Glaxosmithkline, LLC. | $292.15 | 2020-2025 | Ojjaara, Blenrep, Shingrix |
| Sun Pharmaceutical Industries INC. | $288.71 | 2023-2025 | Yonsa |
| Amgen INC. | $287.40 | 2019-2023 | Blincyto, Kyprolis, Xgeva |
| Kite Pharma, INC. | $279.25 | 2021-2023 | Yescarta |
| Beone Medicines USA, INC. | $277.37 | 2025 | Brukinsa |
| Taiho Oncology, INC. | $274.15 | 2019-2025 | |
| Biotronik INC. | $271.56 | 2019-2020 | |
| Adaptive Biotechnologies Corporation | $263.59 | 2024-2025 | Clonoseq |
| Stemline Therapeutics INC. | $258.89 | 2023-2025 | Orserdu |
| Emd Serono, INC. | $255.15 | 2019-2025 | Bavencio |
| Ipsen Biopharmaceuticals, INC | $249.32 | 2022-2025 | Somatuline Depot, Onivyde |
| Jazz Pharmaceuticals INC. | $231.95 | 2019-2025 | Zepzelca |
| Pharmaessentia USA Corporation | $219.30 | 2023-2025 | Besremi |
| Blueprint Medicines Corporation | $197.34 | 2021-2025 | Ayvakit |
| Genmab U.S., INC. | $178.31 | 2023-2025 | Epkinly |
| Tempus Ai, INC | $139.85 | 2024-2025 | Xt Cdx |
| Sumitomo Pharma America, INC. | $135.68 | 2023-2025 | Orgovyx |
| Immunocore Limited | $133.94 | 2023-2025 | Kimmtrak |
| Deciphera Pharmaceuticals INC. | $131.86 | 2021-2025 | Qinlock, Romvimza |
| Agios Pharmaceuticals, INC. | $123.88 | 2019-2025 | Pyrukynd |
| Tesaro, INC. | $120.03 | 2019 | |
| Foundation Medicine, INC. | $118.45 | 2019-2023 | Foundationone Liquid Cdx |
| Coherus Oncology, INC. | $104.93 | 2021-2025 | Loqtorzi |
| Morphosys, US INC. | $102.88 | 2021-2023 | Monjuvi |
| Shield Therapeutics INC | $100.29 | 2023-2025 | Accrufer |
| Kyowa Kirin, INC. | $98.68 | 2020-2025 | Poteligeo |
| Recordati_rare_diseases_inc. | $83.04 | 2025 | Enjaymo |
| Emmaus Medical, INC. | $80.07 | 2020-2024 | Endari |
| Geron Corporation | $77.78 | 2025 | Rytelo |
| Amag Pharmaceuticals, INC. | $76.60 | 2019-2022 | |
| Mirati Therapeutics, INC. | $74.81 | 2023-2024 | Krazati |
| Dova Pharmaceuticals | $72.71 | 2021 | |
| Global Blood Therapeutics, INC. | $69.46 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $66.66 | 2022-2024 | Pylarify |
| Tersera Therapeutics LLC | $63.98 | 2019-2024 | Xermelo |
| Dendreon Pharmaceuticals LLC | $60.63 | 2023-2025 | Provenge |
| Acrotech Biopharma INC. | $60.48 | 2025 | Beleodaq |
| Clovis Oncology, INC. | $50.97 | 2019 | |
| Apellis Pharmaceuticals, INC. | $49.38 | 2023-2025 | Empaveli |
| Immunogen, INC. | $48.90 | 2023-2024 | Elahere, Elahere |
| Shorla Oncology INC. | $48.24 | 2025 | |
| Eusa Pharma (US) LLC | $47.94 | 2019-2022 | |
| Chiesi USA, INC. | $46.66 | 2022-2024 | Ferriprox |
| Servier Pharmaceuticals LLC | $45.03 | 2022-2025 | |
| Medtronic USA, INC. | $44.96 | 2019 | |
| Secura Bio, INC. | $34.97 | 2019-2024 | Copiktra |
| Celltrion USA INC. | $33.76 | 2023 | Vegzelma |
| Cti Biopharma Corp. | $29.64 | 2023 | Vonjo |
| Janssen Scientific Affairs, LLC | $29.29 | 2019 | |
| Adc Therapeutics America, INC. | $29.01 | 2024 | |
| Aimmune Therapeutics, INC. | $27.89 | 2024 | |
| Organon LLC | $27.59 | 2022 | |
| Invivyd INC | $25.43 | 2025 | Pemgarda |
| Springworks Therapeutics, INC. | $24.29 | 2024 | Ogsiveo |
| Fennec Pharmaceuticals, INC. | $23.97 | 2024 | Pedmark |
| Sirtex Medical INC | $22.42 | 2023 | Sir-Spheres Microspheres |
| Alnylam Pharmaceuticals INC. | $22.07 | 2021 | |
| Azurity Pharmaceuticals, INC. | $22.03 | 2025 | Danziten |
| Tg Therapeutics, INC. | $21.87 | 2022 | |
| Caris Mpi, INC. | $21.48 | 2025 | Mi Cancer Seek |
| Epizyme, INC. | $21.02 | 2021 | |
| Verity Pharmaceuticals INC. | $20.66 | 2022 | |
| Myovant Sciences INC. | $19.99 | 2022 | |
| Macrogenics, INC. | $19.54 | 2022 | |
| G1 Therapeutics, INC. | $19.26 | 2023 | Cosela |
| Tolmar Pharmaceuticals, INC. | $18.65 | 2019 | |
| Iovance Biotherapeutics, INC. | $18.40 | 2025 | Amtagvi |
Drugs and devices associated with these payments
Kisqali $2,758Imbruvica $1,161Lenvima $848Keytruda $796Epkinly $795Brukinsa $626Calquence $610Libtayo $550Elrexfio $520Xtandi $493Reblozyl $476Opdivo $457Adcetris $444Enhertu $407Jakafi $391Trodelvy $372Cabometyx $332Orgovyx $327Braftovi $323Jaypirca $313Mektovi $302Lynparza $301Ibrance $299Verzenio $291Yonsa $289Bosulif $282Tukysa $270Clonoseq $264Odomzo $263Orserdu $259Gilotrif $250Opdualag $242Somatuline Depot $231Onivyde $231Fotivda $231Xpovio $231Tavalisse $229Rezlidhia $229Talzenna $226Vitrakvi $226Stivarga $226Ayvakit $223Besremi $219Fruzaqla $211Erleada $199Doptelet $197Monjuvi $190Ultomiris $189Darzalex $185Pluvicto $181Tecvayli $179Tagrisso $174Iclusig $174Nubeqa $173Pemazyre $168Scemblix $166Elahere $166Tecentriq $166Inqovi $157Lonsurf $157Inlyta $154Carvykti $153Retevmo $149Lorbrena $149Xarelto $138Kimmtrak $134Talvey $134Welireg $131Rybrevant $130Ojjaara $123Pomalyst $118Fabhalta $115Promacta $112Padcev $110Zepzelca $108Venclexta $104Paxlovid $102Accrufer $100Comirnaty $98.28Balversa $97.74Sarclisa $96.95Bavencio $89.33Enjaymo $83.04Besponsa $82.12Polivy $82.00Nerlynx $79.90Poteligeo $79.14Gavreto $78.62Rytelo $77.78Krazati $74.81Datroway $72.93Foundationone Liquid Cdx $70.93Akeega $70.83Mekinist $70.47Tivdak $69.39Eliquis $66.57Pyrukynd $66.54Provenge $60.63Beleodaq $60.48Qinlock $58.86
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Cheung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.